Naproxen Sodium
- Product NDC
- 80425-0531
- 11-digit product format
- 804250531
- Labeler code
- 80425
- Product ID
- 80425-0531_4aa4739c-dd97-3368-e063-6294a90a29f8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Advanced Rx of Tennessee, LLC
- Application
- ANDA212199
- Marketing category
- ANDA
- Marketing start
- 2025-06-02
- Substance
- NAPROXEN SODIUM
- Active strength
- 550 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Naproxen Sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NAPROXEN SODIUM | 550 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9TN87S3A3C |
| Rxcui | 849431 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 80425-0531-1 | Naproxen Sodium | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
| 80425-0531-2 | Naproxen Sodium | 60 in 1 BOTTLE | TABLET | 60 | | 2 |
| 80425-0531-3 | Naproxen Sodium | 90 in 1 BOTTLE | TABLET | 90 | | 2 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 80425-0531-1 | 80425053101 | 30 TABLET in 1 BOTTLE (80425-0531-1) | 30 tablet | 2025-06-02 | No | No | Historical |
| 80425-0531-2 | 80425053102 | 60 TABLET in 1 BOTTLE (80425-0531-2) | 60 tablet | 2025-06-02 | No | No | Historical |
| 80425-0531-3 | 80425053103 | 90 TABLET in 1 BOTTLE (80425-0531-3) | 90 tablet | 2025-06-02 | No | No | Historical |